Enrolling Now

Enrolling Now

Once Weekly Medication

Obesity or Overweight and Type 2 Diabetes

See if you qualify

  • Study to Investigate the Efficacy and Safety of Once Weekly Meds in Adult Participants with Obesity or Overweight, and Type 2 Diabetes.

    • ≥18 years of age

    • Clinically diagnosed Type 2 Diabetes and are on stable treatment >3 months consisting of either diet/exercise OR <3 oral AHMs (excluding incretins)

    • BMI ≥27 kg/m2 at screening

    • No obesity management medications within prior 1 year.

    • No Type 1 Diabetes

  • Gain access to cutting-edge medications and treatments before they are widely available.

    Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

    We are highly focused on patient well-being and the highest ethical standards in clinical research.

Locations: Manhattan and Long Island City

Cost to you: none for study visits, tests, or study medication

Questions: 516-574-9232 · Hablamos español

Pre-screen for this study

Answer a few questions and a study coordinator will call you to go over the next steps. Your information is used only to contact you about this study.

A yellow background with a coiled white measuring tape, some white pills scattered near the tape.

Think you may qualify? Fill out this form and a member of our medical research team will be in touch shortly with more information.